Nicholas Hoffman & Company’s Stryker SYK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.08M | Buy |
3,285
+10
| +0.3% | +$3.59K | 0.02% | 141 |
|
|
2025
Q4 | $1.15M | Sell |
3,275
-173
| -5% | -$63K | 0.03% | 130 |
|
|
2025
Q3 | $1.27M | Buy |
3,448
+2
| +0.1% | +$773 | 0.03% | 112 |
|
|
2025
Q2 | $1.36M | Buy |
3,446
+107
| +3% | +$40K | 0.04% | 106 |
|
|
2025
Q1 | $1.24M | Sell |
3,339
-192
| -5% | -$73.1K | 0.05% | 106 |
|
|
2024
Q4 | $1.27M | Sell |
3,531
-558
| -14% | -$207K | 0.05% | 100 |
|
|
2024
Q3 | $1.48M | Buy |
4,089
+138
| +3% | +$47.6K | 0.06% | 93 |
|
|
2024
Q2 | $1.34M | Sell |
3,951
-226
| -5% | -$76.6K | 0.06% | 95 |
|
|
2024
Q1 | $1.49M | Buy |
4,177
+29
| +0.7% | +$9.76K | 0.08% | 83 |
|
|
2023
Q4 | $1.24M | Buy |
4,148
+204
| +5% | +$57.3K | 0.07% | 97 |
|
|
2023
Q3 | $1.08M | Buy |
3,944
+5
| +0.1% | +$1.43K | 0.08% | 103 |
|
|
2023
Q2 | $1.2M | Buy |
3,939
+4
| +0.1% | +$1.16K | 0.05% | 98 |
|
|
2023
Q1 | $1.12M | Sell |
3,935
-38
| -1% | -$10.1K | 0.1% | 103 |
|
|
2022
Q4 | $971K | Buy |
3,973
+4
| +0.1% | +$908 | 0.1% | 117 |
|
|
2022
Q3 | $804K | Buy |
3,969
+5
| +0.1% | +$1.05K | 0.04% | 123 |
|
|
2022
Q2 | $788K | Buy |
3,964
+5
| +0.1% | +$1.17K | 0.04% | 124 |
|
|
2022
Q1 | $1.06M | Sell |
3,959
-34
| -0.9% | -$8.8K | 0.04% | 106 |
|
|
2021
Q4 | $1.07M | Buy |
3,993
+4
| +0.1% | +$1.05K | 0.03% | 107 |
|
|
2021
Q3 | $1.05M | Sell |
3,989
-6
| -0.2% | -$1.6K | 0.18% | 101 |
|
|
2021
Q2 | $1.04M | Sell |
3,995
-37
| -0.9% | -$9.46K | 0.19% | 100 |
|
|
2021
Q1 | $982K | Buy |
4,032
+78
| +2% | +$18.7K | 0.2% | 103 |
|
|
2020
Q4 | $969K | Buy |
3,954
+35
| +0.9% | +$7.93K | 0.22% | 87 |
|
|
2020
Q3 | $817K | Buy |
3,919
+108
| +3% | +$21K | 0.22% | 88 |
|
|
2020
Q2 | $687K | Buy |
3,811
+35
| +0.9% | +$6.46K | 0.2% | 100 |
|
|
2020
Q1 | $629K | Sell |
3,776
-516
| -12% | -$101K | 0.21% | 98 |
|
|
2019
Q4 | $901K | Sell |
4,292
-195
| -4% | -$40.5K | 0.25% | 86 |
|
|
2019
Q3 | $971K | Buy |
4,487
+6
| +0.1% | +$1.29K | 0.3% | 75 |
|
|
2019
Q2 | $921K | Buy |
4,481
+81
| +2% | +$15.5K | 0.29% | 79 |
|
|
2019
Q1 | $869K | Buy |
4,400
+777
| +21% | +$140K | 0.28% | 88 |
|
|
2018
Q4 | $568K | Buy |
3,623
+201
| +6% | +$33.6K | 0.2% | 104 |
|
|
2018
Q3 | $608K | Sell |
3,422
-196
| -5% | -$33.5K | 0.2% | 100 |
|
|
2018
Q2 | $611K | Sell |
3,618
-355
| -9% | -$59.7K | 0.22% | 97 |
|
|
2018
Q1 | $639K | Buy |
3,973
+153
| +4% | +$24.7K | 0.25% | 93 |
|
|
2017
Q4 | $591K | Buy |
3,820
+2
| +0.1% | +$305 | 0.23% | 98 |
|
|
2017
Q3 | $542K | Buy |
3,818
+101
| +3% | +$14.5K | 0.23% | 99 |
|
|
2017
Q2 | $516K | Buy |
3,717
+31
| +0.8% | +$4.25K | 0.23% | 93 |
|
|
2017
Q1 | $485K | Buy |
3,686
+264
| +8% | +$33.4K | 0.23% | 95 |
|
|
2016
Q4 | $409K | Buy |
3,422
+360
| +12% | +$41.4K | 0.21% | 104 |
|
|
2016
Q3 | $356K | Hold |
3,062
| – | – | 0.19% | 102 |
|
|
2016
Q2 | $367K | Buy |
+3,062
| New | +$342K | 0.21% | 95 |
|
Other funds holding SYK
VCM
GT
VPM
Nicholas Hoffman & Company's SYK Position: Q1 2026 in Review
Nicholas Hoffman & Company increased its Stryker (SYK) stake by 0.31% in Q1 2026, buying an estimated $3.59K and bringing the position to 3,285 shares worth $1.08M. The position accounts for 0.02% of the portfolio, ranked #141.
Nicholas Hoffman & Company first reported a position in SYK in Q2 2016 and has held it in 40 quarters since. The position peaked at $1.49M in Q1 2024. 2,295 funds tracked by Wall St. Rank hold SYK as of Q1 2026.
- Nicholas Hoffman & Company held 3,285 shares of Stryker worth $1.08M as of Q1 2026.
- Nicholas Hoffman & Company bought 10 Stryker shares in Q1 2026, an estimated $3.59K.
- Stryker made up 0.02% of Nicholas Hoffman & Company's portfolio in Q1 2026, its #141 holding.
- Nicholas Hoffman & Company first reported a position in Stryker in Q2 2016 and has held it in 40 quarters since.
- Nicholas Hoffman & Company's Stryker position peaked at $1.49M in Q1 2024.
- 2,295 funds tracked by Wall St. Rank held Stryker as of Q1 2026.
Based on Nicholas Hoffman & Company's 13F filing for Q1 2026, filed 29 Apr 2026.